GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Cash, Cash Equivalents, Marketable Securities

Gerresheimer AG (XTER:GXI) Cash, Cash Equivalents, Marketable Securities : €123 Mil (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Cash, Cash Equivalents, Marketable Securities?

Gerresheimer AG's quarterly cash, cash equivalents, marketable securities increased from Aug. 2023 (€133.46 Mil) to Nov. 2023 (€136.75 Mil) but then stayed the same from Nov. 2023 (€136.75 Mil) to Feb. 2024 (€123.17 Mil).

Gerresheimer AG's annual cash, cash equivalents, marketable securities declined from Nov. 2021 (€130.29 Mil) to Nov. 2022 (€124.83 Mil) but then increased from Nov. 2022 (€124.83 Mil) to Nov. 2023 (€136.75 Mil).


Gerresheimer AG Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Gerresheimer AG's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Cash, Cash Equivalents, Marketable Securities Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.06 100.75 130.29 124.83 136.75

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.67 133.02 133.46 136.75 123.17

Gerresheimer AG Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Gerresheimer AG  (XTER:GXI) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Gerresheimer AG Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Industry
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines